Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 44,044 | 37,929 | 30,015 | 30,542 | 38,783 |
| Cost of Goods | 2,113 | 1,051 | 1,301 | 1,331 | 1,300 |
| Gross Profit | 41,931 | 36,878 | 28,714 | 29,211 | 37,483 |
| Operating Expenses | 57,264 | 61,316 | 62,271 | 60,823 | 64,066 |
| Operating Income | -15,220 | -24,387 | -33,256 | -31,281 | -26,283 |
| Interest Expense | 11,008 | 11,228 | 10,994 | 11,204 | 11,385 |
| Other Income | -6,865 | -1,597 | 20,824 | 11,596 | 5,624 |
| Pre-tax Income | -33,093 | -37,212 | -23,426 | -30,889 | -32,044 |
| Income Tax | 34 | 40 | 36 | -109 | 28 |
| Net Income Continuous | -33,127 | -37,252 | -23,462 | -30,780 | -32,072 |
| Net Income | $-33,127 | $-37,252 | $-23,462 | $-30,780 | $-32,072 |
| EPS Basic Total Ops | -3.82 | -4.32 | -2.77 | -3.01 | -3.85 |
| EPS Basic Continuous Ops | -3.82 | -4.32 | -2.77 | -3.65 | -3.85 |
| EPS Diluted Total Ops | -3.82 | -4.32 | -2.77 | -2.27 | -3.85 |
| EPS Diluted Continuous Ops | -3.82 | -4.32 | -2.77 | -2.65 | -3.85 |
| EPS Diluted Before Non-Recurring Items | -3.82 | -4.32 | -2.77 | -3.60 | -3.90 |
| EBITDA(a) | $-12,336 | $-21,709 | $-30,841 | $-29,235 | $-24,324 |